Journals / Turkish Neurosurgery / 2015 / Cilt: 25 - Sayı: 1

Onyx Embolizasyonu ve Gamma Bıçağı Radyocerrahisi ile Beyin AVM lerinin Kombine Tedavisi Obliterasyon Oranının Düşük Olmasına Karşın Kanama Riskinde Azalma

Combined Treatment of Brain AVMs by Onyx Embolization and gamma knife Radiosurgery Decreased Hemorrhage Risk Despite low Obliteration Rate

Pages
100–110
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Long-term follow-up and larger population are needed for evaluating the clinical effect for this combined treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: The effectiveness and risk of cerebral arteriovenous malformations (AVMs) treatment with Onyx embolization combined with Gamma Knife surgery (GKS) were rarely reported.
📊
Key Findings & Data:MATERIAL and METHODS: A total of 86 patients clinical outcomes were fully collected.
💡
Conclusion & Impact:Long-term follow-up and larger population are needed for evaluating the clinical effect for this combined treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: The effectiveness and risk of cerebral arteriovenous malformations (AVMs) treatment with Onyx embolization combined with Gamma Knife surgery (GKS) were rarely reported. In the present study, we analyzed the radiographic and clinical outcomes of combined Onyx embolization and GKS for cerebral AVMs. MATERIAL and METHODS: A total of 86 patients clinical outcomes were fully collected. Modalities and complications of the procedure were analyzed as well as the clinical and anatomic outcomes. Risk factors associated with hemorrhage were determined by multivariate analysis. RESULTS: The mean duration of radiological and clinical follow-up was 42 months (12.3-82.5 months) and 57.6 months (12.3-108.9 months), respectively. The total annual hemorrhage rate was 1.66% with 2.26% for ruptured AVMs and 1.08% for unruptured AVMs. The annual mortality rate was 0.4%. The total obliteration rate was 28.2% at follow-up. Clinical deterioration occurred in 4 patients (4.7%). Volume larger than 22 ml, diameter prior GKS larger than 3.5 cm and margin dose less than 16 Gy significantly increased the hemorrhage risk. CONCLUSION: The post-treatment hemorrhage could be predictable based on AVM s characteristics and treatment approaches. The annual hemorrhage rate was low for both ruptured and unruptured AVMs after combined treatment; however, the total obliteration rate was low. Long-term follow-up and larger population are needed for evaluating the clinical effect for this combined treatment.

Özet

AMAÇ: Onyx embolizasyonu ile kombine Gamma Bıçağı cerrahisi (GBC) ile serebral arteriyovenöz malformasyonların (AVMler) tedavisinin etkinliği ve riski nadiren bildirilmiştir. Mevcut çalışmada serebral AVMler için kombine Onyx embolizasyonu ve GBCnin radyografik ve klinik sonuçlarını analiz ettik. YÖNTEM ve GEREÇLER: Toplam 86 hastanın klinik sonuçları tam olarak toplandı. İşlemin modaliteleri ve komplikasyonları ve ayrıca klinik ve anatomik sonuçlar analiz edildi. Kanama ile ilişkili risk faktörleri multivaryant analiz ile belirlendi. BULGULAR: Radyolojik ve klinik takibin ortalama süresi sırasıyla 42 ay (12,3-82,5 ay) ve 57,6 ay (12,3-108,9 ay) bulundu. Toplam yıllık kanama oranı rüptüre AVMler için %2,26 ile rüptüre olmamış AVMler için %1,08 ve toplam olarak %1,66 bulundu. Yıllık mortalite oranı %0,4tü. Toplam obliterasyon oranı takipte %28,2 bulundu. Klinik bozulma 4 hastada (%4,7) görüldü. Hacmi 22 ml üstünde olması, GKS öncesinde çapın 3,5 cmden fazla olması ve üst sınır dozunu 16 Gyin altında olması kanama riskini önemli ölçüde artırdı. SONUÇ: Tedavi sonrası kanama AVMnin özellikleri ve tedavi yaklaşımları temelinde öngörülebiliyordu. Yıllık kanama oranı kombine tedavi sonrasında rüptüre olan ve olmayan AVMler için düşüktü; ancak toplam obliterasyon oranı da düşüktü. Bu kombine tedavinin klinik etkisini değerlendirmek için uzun dönemli takip ve daha büyük bir popülasyon gereklidir.

🔖

Cite This Article

HUO, X., LI, Y., WU, Z., JIANG, Y., YANG, H., ZHAO, Y. (2015). Onyx Embolizasyonu ve Gamma Bıçağı Radyocerrahisi ile Beyin AVM lerinin Kombine Tedavisi Obliterasyon Oranının Düşük Olmasına Karşın Kanama Riskinde Azalma. Turkish Neurosurgery, Cilt: 25 - Sayı: 1, 100–110. https://ajindex.com/articles/405410

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Andrade-Souza YM, Ramani M, Scora D, Tsao MN, terBrugge K, Schwartz ML: Embolization before radiosurgery reduces the obliteration rate of arteriovenous malformations. Neurosurgery 60:443-451; discussion 451-442, 2007 2. Blackburn SL, Ashley WW Jr, Rich KM, Simpson JR, Drzymala RE, Ray WZ, Moran CJ, Cross DT 3rd, Chicoine MR, Dacey RG Jr, Derdeyn CP, Zipfel GJ: Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. Journal of Neurosurgery 114:1758-1767, 2011 3. Brown RD Jr, Wiebers DO, Forbes G, O’Fallon WM, Piepgras DG, Marsh WR, Maciunas RJ: The natural history of unrup- tured intracranial arteriovenous malformations. Journal of Neurosurgery 68:352-357, 1988 4. Dawson RC 3rd, Tarr RW, Hecht ST, Jungreis CA, Lunsford LD, Coffey R, Horton JA: Treatment of arteriovenous malformations of the brain with combined embolization and stereotactic radiosurgery: Results after 1 and 2 years. AJNR American Journal of Neuroradiology 11:857-864, 1990 5. DeMeritt JS, Pile-Spellman J, Mast H, Moohan N, Lu DC, Young WL, Hacein-Bey L, Mohr JP, Stein BM: Outcome analysis of preoperative embolization with N-butyl cyanoacrylate in cerebral arteriovenous malformations. AJNR American Journal of Neuroradiology 16:1801-1807, 1995 6. Ding D, Yen CP, Xu Z, Starke RM, Sheehan JP: Radiosurgery for patients with unruptured intracranial arteriovenous malformations. Journal of Neurosurgery 118:958-966, 2013 7. Fleetwood IG, Steinberg GK: Arteriovenous malformations. Lancet 359:863-873, 2002 8. Fox AJ, Girvin JP, Vinuela F, Drake CG: Rolandic arteriovenous malformations: Improvement in limb function by IBC embolization. AJNR American Journal of Neuroradiology 6:575-582, 1985 9. Gobin YP, Laurent A, Merienne L, Schlienger M, Aymard A, Houdart E, Casasco A, Lefkopoulos D, George B, Merland JJ: Treatment of brain arteriovenous malformations by embolization and radiosurgery. Journal of Neurosurgery 85:19-28, 1996 10. Gross BA, Du R: Natural history of cerebral arterioveno malformations: A meta-analysis. Journal of Neurosurge 118:437-443, 2013 11. Guo WY, Wikholm G, Karlsson B, Lindquist C, Svends P, Ericson K: Combined embolization and gamma kni radiosurgery for cerebral arteriovenous malformations. Ac radiologica 34:600-606, 1993 12. Henkes H, Nahser HC, Berg-Dammer E, Weber W, Lan S, Kuhne D: Endovascular therapy of brain AVMs prior radiosurgery. Neurological Research 20:479-492, 1998 13. Jafar JJ, Davis AJ, Berenstein A, Ch